Free Delivery Over $100
|
|
|||
|
||||
OverviewWhen a biological drug patent expires, alternative biosimilar products are developed. The development of biosimilar products is complicated and involves numerous considerations and steps. The assessment of biosimilarity and interchangeability is also complicated and difficult. Biosimilar Drug Product Development presents current issues for the development of biosimilars and gives detailed reviews of its various stages and contributing factors as well as relevant regulatory pathways and pre- and post-approval issues. Full Product DetailsAuthor: Laszlo Endrenyi (University of Toronto, Canada) , Shein-Chung Chow , . Paul DeclerckPublisher: Taylor & Francis Ltd Imprint: CRC Press Weight: 0.712kg ISBN: 9780367552497ISBN 10: 0367552493 Pages: 496 Publication Date: 30 June 2020 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationLaszlo Endrenyi, Professor Emeritus, University of Toronto Tab Content 6Author Website:Countries AvailableAll regions |
||||
